NTIDs # HVDs (or not?) [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-08 14:24 (5858 d 05:28 ago) – Posting: # 5468
Views: 10,659

Hi Helmut

❝ If we are talking about immunosuppressants, we are talking about a study in patients, right? Steady state too. Likely parallel design – it’s unethical to interrupt treatment by a washout.


If you investigate steady state PK you can do an "active washout" without interrupting treatment.

Regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
146 visitors (0 registered, 146 guests [including 37 identified bots]).
Forum time: 19:52 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5